Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, octobre 20
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Bluejay Diagnostics Inc
BJDX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.6705
-0.0259
-3.72%
Dern. MÀJ: Oct 20, 6:53 PM
$0.6850
-0.0114
-1.64%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Bluejay Diagnostics Financials
Bluejay Diagnostics (BJDX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.41) per share. This is a 99.45 percent increase over losses of $(256.16) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.
Benzinga Newsdesk
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
Avi Kapoor
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March
Avi Kapoor
